D-1401-2012 Class III Terminated
FDA drug recall D-1401-2012 was initiated by Watson Laboratories Inc on Apr 17, 2012 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged. The recall status is terminated (terminated Mar 18, 2013). Affected quantity: 21,572 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 11, 2012
- Initiation Date
- Apr 17, 2012
- Termination Date
- Mar 18, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 21,572 bottles
Product description
Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0371-01
Reason for recall
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
Distribution pattern
Nationwide.
Code information
Lot #s: 101696A, 110829A, 123685A, 123687A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1401-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026